Data / Drug companies / Quality Care Products, LLC
Quality Care Products, LLC: 20 products in the FDA NDC directory, labeler code 83008
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Quality Care Products, LLC (labeler code 83008) lists 20 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 20 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 18, 2024.
The request: Watch Quality Care Products, LLC (FDA labeler code 83008): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83008
- Products in commercial distribution
- 20
- Packages
- 27
- Finished drugs by generic name
- 16
- Prescription products
- 20
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 20
- Earliest marketing start
- March 3, 2023
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 19 | 95% |
| Authorized generics (NDA) | 1 | 5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 20 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ibuprofen | 2 | 190 |
| Lidocaine | 2 | 216 |
| Diclofenac sodium | 2 | 109 |
| Irbesartan | 2 | 27 |
| Pantoprazole sodium | 1 | 54 |
| Azithromycin dihydrate | 1 | 20 |
| Bupropion hydrochloride | 1 | 67 |
| Diclofenac epolamine | 1 | 11 |
| Baclofen | 1 | 65 |
| Celecoxib | 1 | 63 |
| Losartan potassium and hydrochlorothiazide | 1 | 31 |
| Tramadol hydrochloride | 1 | 44 |
| Ondansetron hydrochloride | 1 | 48 |
| Amlodipine besylate | 1 | 49 |
| Atenolol | 1 | 36 |
| Famotidine | 1 | 138 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 35% |
| Tablet, film coated | 4 | 20% |
| Ointment | 2 | 10% |
| Tablet, delayed release | 1 | 5% |
| Tablet, film coated, extended release | 1 | 5% |
| System | 1 | 5% |
| Capsule | 1 | 5% |
| Solution | 1 | 5% |
| Gel | 1 | 5% |
| Tablet, extended release | 1 | 5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Famotidine | 83008-091 | Tablet, film coated | Generic drugs (ANDA) | September 18, 2024 |
| Losartan Potassium and Hydrochlorothiazide | 83008-086 | Tablet, film coated | Generic drugs (ANDA) | August 28, 2024 |
| Irbesartan | 83008-085 | Tablet | Generic drugs (ANDA) | August 28, 2024 |
| Irbesartan | 83008-084 | Tablet | Generic drugs (ANDA) | August 28, 2024 |
| Bupropion Hydrochloride (XL) | 83008-082 | Tablet, film coated, extended release | Generic drugs (ANDA) | August 28, 2024 |
| Azithromycin Dihydrate | 83008-081 | Tablet, film coated | Generic drugs (ANDA) | August 28, 2024 |
| Ondansetron Hydrochloride | 83008-074 | Tablet, film coated | Generic drugs (ANDA) | July 25, 2024 |
| Lidocaine | 83008-067 | Ointment | Generic drugs (ANDA) | July 23, 2024 |
| Ibuprofen | 83008-066 | Tablet | Generic drugs (ANDA) | July 8, 2024 |
| Lidocaine | 83008-044 | Ointment | Generic drugs (ANDA) | June 26, 2024 |
| Baclofen | 83008-062 | Tablet | Generic drugs (ANDA) | May 21, 2024 |
| Atenolol | 83008-052 | Tablet | Generic drugs (ANDA) | January 25, 2024 |
| Ibuprofen | 83008-050 | Tablet | Generic drugs (ANDA) | January 17, 2024 |
| Diclofenac epolamine | 83008-036 | System | Authorized generics (NDA) | August 15, 2023 |
| Diclofenac Sodium | 83008-037 | Gel | Generic drugs (ANDA) | August 4, 2023 |
| Amlodipine Besylate | 83008-035 | Tablet | Generic drugs (ANDA) | July 20, 2023 |
| Pantoprazole Sodium | 83008-034 | Tablet, delayed release | Generic drugs (ANDA) | July 18, 2023 |
| Diclofenac sodium | 83008-019 | Solution | Generic drugs (ANDA) | May 2, 2023 |
| Celecoxib | 83008-013 | Capsule | Generic drugs (ANDA) | April 25, 2023 |
| Tramadol hydrochloride | 83008-009 | Tablet, extended release | Generic drugs (ANDA) | March 3, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.